BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 27216613)

  • 1. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.
    Lavorini F; Mannini C; Chellini E; Fontana GA
    Drugs Aging; 2016 Jul; 33(7):461-73. PubMed ID: 27216613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing drug delivery in COPD: The role of inhaler devices.
    Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
    Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for managing chronic obstructive pulmonary disease in the elderly.
    Taffet GE; Donohue JF; Altman PR
    Clin Interv Aging; 2014; 9():23-30. PubMed ID: 24376347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol Delivery Devices for Obstructive Lung Diseases.
    Pleasants RA; Hess DR
    Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN; Bjermer L; Lavorini F; Ninane V; Molimard M; Haughney J
    Respir Med; 2014 May; 108(5):694-700. PubMed ID: 24636812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 9. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
    Pepper AN; Cooke A; Livingston L; Lockey RF
    Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of nebulized drug delivery in COPD.
    Tashkin DP
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2585-2596. PubMed ID: 27799757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized Therapies in COPD: Past, Present, and the Future.
    Barjaktarevic IZ; Milstone AP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1665-1677. PubMed ID: 32764912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.
    González-Torralba F; Baloira A; Abad A; Fuster A; García-Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1005-1015. PubMed ID: 35547784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching treatments in COPD: implications for costs and treatment adherence.
    Braido F; Lavorini F; Blasi F; Baiardini I; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2601-8. PubMed ID: 26664108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device errors in asthma and COPD: systematic literature review and meta-analysis.
    Chrystyn H; van der Palen J; Sharma R; Barnes N; Delafont B; Mahajan A; Thomas M
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):22. PubMed ID: 28373682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L; Goodwin E; Walsh J
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
    Barrons R; Pegram A; Borries A
    Am J Health Syst Pharm; 2011 Jul; 68(13):1221-32. PubMed ID: 21690428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metered-dose inhalers and dry powder inhalers in aerosol therapy.
    Hess DR
    Respir Care; 2005 Oct; 50(10):1376-83. PubMed ID: 16185372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease.
    Mahler DA
    Respir Med; 2020 Jan; 161():105857. PubMed ID: 32056720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.